<Header>
<FileStats>
    <FileName>20241023_10-Q_edgar_data_1593773_0001477932-24-006633.txt</FileName>
    <GrossFileSize>2297914</GrossFileSize>
    <NetFileSize>42417</NetFileSize>
    <NonText_DocumentType_Chars>482532</NonText_DocumentType_Chars>
    <HTML_Chars>555925</HTML_Chars>
    <XBRL_Chars>493699</XBRL_Chars>
    <XML_Chars>677686</XML_Chars>
    <N_Exhibits>7</N_Exhibits>
</FileStats>
<SEC-Header>
0001477932-24-006633.hdr.sgml : 20241023
<ACCEPTANCE-DATETIME>20241023121139
ACCESSION NUMBER:		0001477932-24-006633
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20240831
FILED AS OF DATE:		20241023
DATE AS OF CHANGE:		20241023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMJ Global Technology
		CENTRAL INDEX KEY:			0001593773
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				331230169
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-194055
		FILM NUMBER:		241388390

	BUSINESS ADDRESS:	
		STREET 1:		2470 E FLAMINGO RD
		STREET 2:		SUITE A
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89121
		BUSINESS PHONE:		213-709-4296

	MAIL ADDRESS:	
		STREET 1:		2470 E FLAMINGO RD
		STREET 2:		SUITE A
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KANGE CORP
		DATE OF NAME CHANGE:	20131209

</SEC-Header>
</Header>

 0001477932-24-006633.txt : 20241023

10-Q
 1
 kgnr_10q.htm
 FORM 10-Q

kgnr_10q.htm 
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (IRS Employer Identification Number) , , (Address of principal executive offices) ) (Registrant s telephone number, including area code) ______________________________________________ (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: None. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No As of October 22, 2024, the Company had shares of common stock outstanding. AMJ Global Technology INDEX Page PART I. FINANCIAL INFORMATION Item 1. Financial Statements 3 Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations 4 Item 3. Quantitative and Qualitative Disclosures about Market Risks 8 Item 4. Controls and Procedures 8 PART II. OTHER INFORMATION Item 1. Legal Proceedings 9 Item 1A. Risk Factors 9 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 9 Item 3. Defaults Upon Senior Securities 9 Item 4. Mine Safety Disclosures 9 Item 5. Other Information 9 Item 6. Exhibits 10 SIGNATURES 11 2 Table of Contents PART I FINANCIAL INFORMATION Item 1. Financial Statements AMJ Global Technology Table of Contents Page Condensed Balance Sheets at August 31, 2024 and November 30, 2023 (unaudited) F-1 Condensed Statements of Operations for the three and nine months ended August 31, 2024, and 2023 (unaudited) F-2 Condensed Statements of Changes in Stockholders Equity (Deficit) for the three and nine months ended August 31, 2024, and 2023 (unaudited) F-3 Condensed Statements of Cash Flows for the nine months ended August 31, 2024, and 2023 (unaudited) F-5 Notes to Unaudited Condensed Financial Statements F-6 3 Table of Contents A MJ Global Technology Condensed Balance Sheets (Unaudited) August 31, November 30, 2024 2023 ASSETS Current Assets Cash Accounts receivable - related party Prepaid expenses Total Current Assets Software and technology assets Medicare contracts asset TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable Accrued management fees - related party Due to related party Total Current Liabilities Stockholders' Deficit Common stock, par value, shares authorized, and shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total Stockholders' Deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT The accompanying notes are an integral part of these unaudited condensed financial statements. F-1 Table of Contents AMJ Global Technology Condensed Statements of Operations (Unaudited) Three Months Ended Nine Months Ended August 31, August 31, 2024 2023 2024 2023 Revenues -related party Operating Expenses General and administrative Professional fees Management compensation Total operating expenses Operating loss Other income Gain on settlement of debt - related party Total other income Net loss before income taxes Provision for income taxes Net Loss Basic and diluted loss per common share Basic and diluted weighted average common shares outstanding Prior period has been restated, see Note 1 Basis of Presentation Restatement of Previously Issued Financial Statements. The accompanying notes are an integral part of these unaudited condensed financial statements. F-2 Table of Contents AMJ Global Technology Condensed Statement of Changes in Stockholders Deficit (Unaudited) For the Three and Nine Months Ended August 31, 2024 Additional Total Common Stock Paid in Accumulated Stockholders' Shares Amount Capital Deficit Deficit Balance - November 30, 2023 Net loss for the period - Balance - February 29, 2024 Common stock issued for settlement of debt- related party Common stock issued for compensation - related party Common stock issued for services - related party Net income for the period - Balance - May 31, 2024 Common stock issued for software and development acquisition Common stock issued for revenue sharing agreement -related party Common stock issued for compensation - related party Common stock issued for services - related party Net loss for the period - Balance - August 31, 2024 F-3 Table of Contents For the Three and Nine Months Ended August 31, 2023 Additional Total Common Stock Paid in Accumulated Stockholders' Shares Amount Capital Deficit Deficit Balance - November 30, 2022 Net loss for the period - Balance - February 28, 2023 Common stock issued for services - related party Net loss for the period - Balance - May 31, 2023 Net loss for the period - Balance - August 31, 2023 Prior period has been restated, see Note 1 Basis of Presentation Restatement of Previously Issued Financial Statements. The accompanying notes are an integral part of these unaudited condensed financial statements. F-4 Table of Contents AMJ Global Technology Condensed Statements of Cash Flows (Unaudited) Nine Months Ended August 31, 2024 2023 CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash used in operating activities: Management compensation Gain on settlement of debt - related party Changes in operating assets and liabilities: Accounts receivable - related party Prepaid expenses Accounts payable Accrued expenses - related party Accrued management fee - related party Net cash used in operating activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from related party Net cash provided by financing activities Net change in cash for the period Cash at beginning of period Cash at end of period SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for income taxes Cash paid for interest NON-CASH INVESTING AND FINANCING ACTIVITIES Common stock issued for settlement of debt - related party Common stock issued for compensation - related party Common stock issued for services - related party Common stock issued for software and development acquisition Common stock issued for revenue sharing agreement - related party Prior period has been restated, see Note 1 Basis of Presentation Restatement of Previously Issued Financial Statements The accompanying notes are an integral part of these unaudited condensed financial statements. F-5 Table of Contents AMJ Global Technology Notes to Unaudited Condensed Financial Statements August 31, 2024 right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover s Algorithm. The ElephantSqlDB database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks Basis of Presentation Use of Estimates Accounts Receivable F-6 Table of Contents Equity Investment Related Party . Intangible Assets Net Loss Per Share of Common Stock F-7 Table of Contents and at August 31, 2024 and November 30, 2023, respectively. Restatement of Previously Issued Financial Statements Net loss Statements of Cash Flows: Adjustments to reconcile net loss to net cash used in operating activities: Management compensation Statements of Changes in Stockholder's Deficit : Accumulated deficit for the nine months ended August 31, 2024. The Company had an accumulated deficit of at August 31, 2024. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts. The condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. F-8 Table of Contents Medicare contracts asset On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company will receive of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales in exchange for shares of common stock for a unlimited period. The Company issued shares of common stock issued on July 10, 2024, valued at . For the period of July 13, 2024 (inception) to August 31, 2024, the Company recognized revenue in connection with net revenue generated from two contracts. On August 25, 2024, the Company entered into a Software Purchase and Development agreement, pursuant to which the Company acquired an interest in database software and related technology assets in exchange for shares of common stock. The Company issued shares of common stock on August 26, 2024, valued at . of the ownership rights to AMJ Global Entertainment s intellectual property in connection with the Blabeey platform, including software, code and trade secrets at zero cost. During the nine months ended August 31, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company s CEO and director advanced to the Company an amount of and by paying for operating expenses on behalf of the Company and and in cash, respectively. During the nine months ended August 31, 2024, and 2023, the Company recognized management fees of and , respectively. During the nine months ended August 31, 2024 and 2023, the Company issued and shares of common stock to advisory board members, the shares were valued and recognized compensation of and , respectively. During the nine months ended August 31, 2024, the Company issued shares of common stock to the Company s CEO and director and four board of directors members, the shares were valued and recognized compensation of . During the nine months ended August 31, 2024, the Company s board of directors approved the issuance of shares of common stock for settlement of management fees payable to the Company s CEO and director. The shares were valued at , resulting in a gain of settlement on debt of . During the nine months ended August 31, 2024, the Company s board of directors approved the issuance of shares of common stock for settlement of due to AMJ Global Entertainment, LLC, a related party controlled by the Company s CEO. The shares were valued at , resulting in a gain of settlement on debt of . F-9 Table of Contents office rent expenses to a company controlled by a related party. On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company acquired net revenue generated from two contracts of Medicare enrollees, life and annuity insurance, in exchange for shares of common stock, valued at . For the period of July 13,2024 (inception) to August 31, 2024, the Company recognized review sharing of . At August 31, 2024 and November 30, 2023, the Company owed and , respectively, to AMJ Global Entertainment LLC, a related party controlled by the Company s CEO and director. The amount is unsecured, non-interest bearing and due on demand. , par value per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights. During the nine ended August 31, 2023, the Company issued following shares: shares of common stock to the Company s board advisories, valued at . During the nine months ended August 31, 2024, the Company issued following shares: shares of common stock to the Company s CEO and director, valued at . shares of common stock to the Company s board of directors, valued at . shares of common stock to the Company s advisory board members, valued at . shares of common stock against management fees payable to the Company s CEO and director, valued at . shares of common stock against amounts owed to AMJ Global Entertainment LLC, a related party controlled by the Company s CEO and director, valued at . shares of common stock issued for Medicare contracts asset, valued at shares of common stock issued for software and development acquisition, valued at There were and shares of common stock issued and outstanding as of August 31, 2024, and November 30, 2023, respectively. . F-10 Table of Contents Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as anticipate, expects, intends, plans, believes, seeks and estimates and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for AMJ Global Technology. Such a discussion represents only the best present assessment from our Management. Description of Company AMJ Global Technology (the Company was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology. We previously focused on developing mobile software. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We focused on formulating a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer s. On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25 of the ownership rights to AMJ Global Entertainment s intellectual property in connection with the Blabeey platform, including software, code and trade secrets at zero cost. The Company is currently focusing its operations on opportunities in the wholistic health industry. In July of 2024, the Company entered into Revenue Sharing Agreement with Dark Bull Capital, Inc., a Nevada corporation Dark Bull ), pursuant to which the Company would issue 133,334 shares of Company common stock to Dark Bull, and the Company would receive 5 of the net revenue generated by Dark Bull from Dark Bull s contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales. In August of 2024,, the Company entered into a Software Purchase and Development Agreement with Dataark Systems LLC, a Texas LLC Dataark ), pursuant to which the Company acquired an 8 interest in Dataark s ElephantSqlDB database software in consideration of the issuance of 1,333,333 shares of Company common stock to Dataark. The ElephantSqlDB database software is designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover s Algorithm. The ElephantSqlDB database is differentiated from its competitors in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The objective of this technology is to target and cut cloud infrastructure costs significantly while providing immutable security in order to combat evolving threats such as ransomware attacks. We have had limited operations and have been issued a going concern opinion by our auditor on our November 30, 2023, audited financial statements based upon our reliance on related party advances and the sale of our common stock as the sole source of funds for our operations for the near future. The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q. 4 Table of Contents Reports to Security Holders We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We voluntarily file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission in order to disclose relevant information regarding the Company. We may also file additional documents with the Commission if they become necessary in the course of our company s operations. The public may read and copy any materials that we file with the SEC at the SEC s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov. Results of Operations The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed financial statements and notes thereto for the period ended August 31, 2024, which are included herein. Our operating results for the nine months ended August 31, 2024, and 2023 and the changes between those periods for the respective items are summarized as follows. For the Three Months Ended August 31, 2024, and 2023 Three Months Ended August 31, Change 2024 2023 Amount Revenue -related party 8 - 8 Operating loss 50,833 14,550 36,283 Net loss 50,825 14,550 36,275 We generated operating revenues-related party of 8 for the three months ended August 31, 2024. The revenue is related to the revenue sharing agreement with Dark Bull, a company controlled by a related party, as described above and pursuant to which the Company acquired 5 of Dark Bull s net revenue generated from two contracts related to Medicare enrollees, life and annuity insurance. The Company incurred a net loss of 50,825 during the three months ended August 31, 2024, compared to a net loss of 14,550 for the three months ended August 31, 2023. The increase in net loss was primarily due to an increase in management compensation. Operating expenses for the three months ended August 31, 2024, and 2023, were 350,833 and 14,550 respectively. For the three months ended August 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of 35,764 and 0, professional fees of 7,949 and 14,550, and general and administrative expenses of 7,120 and 0, respectively. For the Nine Months Ended August 31, 2024, and 2023 Nine Months Ended August 31, Change 2024 2023 Amount Revenue 8 - 8 Operating loss 145,601 790,503 (644,902 Other income (98,109 - (98,109 Net loss 47,484 790,503 (743,019 5 Table of Contents We generated operating revenues-related party of 8 for the nine months ended August 31, 2024.The revenue is related to the revenue sharing agreement described above. The Company incurred a net loss of 47,484 during the nine months ended August 31, 2024, compared to a net loss of 790,503 for the nine months ended August 31, 2023. The decrease in net loss was primarily due to a reduction in management compensation and offset by other income for a gain on settlement of debt - related party. Operating expenses for the nine months ended August 31, 2024, and 2023, were 145,601 and 790,503 respectively. For the nine months ended August 31, 2024, and 2023, the operating expenses were primarily attributed to management compensation of 97,859 and 752,380, professional fees of 37,622 and 36,323, and general and administrative expenses of 10,120 and 1,800, respectively. Other income for the nine months ended August 31, 2024, was 98,109 for a gain on settlement of debt - related party. Balance Sheet Data August 31, November 30, Increase 2024 2023 (Decrease) Cash 229 - 229 Total Assets 7,559 9,140 (1,581 Total Liabilities 161,021 127,215 33,806 Working Capital (deficiency) (157,170 (118,075 (39,095 Liquidity and Capital Resources Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8 right and interest on software, certain additional and related assets belonged to a technology company specializing in the development. This operation will generate revenue and cashflow for the Company. Working Capital As of August 31, 2024, our current assets were 3,851, and our current liabilities were 161,021, which resulted in working capital deficiency of 157,170. As of August 31, 2024, current assets were comprised of 229 in cash, 8 in accounts receivable - related party and 3,614 in prepaid expenses, compared to 0 in cash and 9,140 in prepaid expenses as of November 30, 2023. As of August 31, 2024, current liabilities were comprised of 3,393 in accounts payable, 150,000 in accrued management fees - related party, and 7,628 in due to related party, compared to 750 in accounts payable, 110,000 in accrued management fees - related party, and 16,465 in amounts due to a related party as of November 30, 2023. Our increase in working capital deficiency is primarily due to an increase in amounts due to a related party and a decrease in cash and prepaid expenses. 6 Table of Contents Cash Flow Data Nine Months Ended August 31, 2024 2023 Cash used in operating activities (39,573 (34,653 Cash provided by financing activities 39,802 34,653 Net change in cash for the period 229 - Cash Flows from Operating Activities We did not generate positive cash flows from operating activities for the nine months ended August 31, 2024, and 2023. For the nine months ended August 31, 2024, net cash flows used in operating activities was 39,573, consisting of a net loss of 3,917,721, reduced by management compensation of 3,878,096, accrued management fees - related party of 90,000, changes in operating assets and liabilities of 8,161, and increased by a gain on settlement of debt related party of 98,109. For the nine months ended August 31, 2023, net cash flows used in operating activities was 34,653 consisting of a net loss of 790,503, reduced by management compensation of 2,380, accrued expenses - related party of 750,000, and a change in operating assets and liabilities of 3,470. Cash Flows from Investing Activities For the nine months ended August 31, 2024, and 2023, no cashflows were used in or provided by investing activities. Cash Flows from Financing Activities We fund our operations with cash received from advances from officers and related parties and issuances of equity. During the nine months ended August 31, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company s CEO and director, advanced to the Company 39,802 and 34,653, respectively, by paying for operating expenses on behalf of the Company. Critical Accounting Policies Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Concentration As of August 31, 2024, and for the nine months ended August 31, 2024, customer and revenue concentrations (more than 10 were 100 related to one revenue sharing agreement with a related party. 7 Table of Contents Off-Balance Sheet Arrangements The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK . As the Company is a smaller reporting company, this item is inapplicable. ITEM 4. CONTROLS AND PROCEDURES. Disclosure Controls and Procedures The Securities and Exchange Commission defines the term disclosure controls and procedures to mean the company s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure. As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives. Changes in Internal Control over Financial Reporting There were no changes in the Company s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended August 31, 2024, that have materially affected, or are reasonably likely to materially affect, the Company s internal control over financial reporting. 8 Table of Contents PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS. The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0 of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation. ITEM 1A. RISK FACTORS. Not applicable. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. None. ITEM 3. DEFAULTS UPON SENIOR SECURITIES. During the period ended May 31, 2024, the Company issued 1,002,200 shares of common stock for settlement of debts, compensation-related party, and services-related party, as follows: On July 10, 2024, the Company issued 133,334 shares of common stock to Dark Bull, a company controlled by a related party, pursuant to the revenue sharing agreement described above, valued at 337. On August 6, 2024, the Company issued 2,000,000 shares of common stock to the Company s CEO, Dr. Arther Malone, Jr., as compensation, valued at 5,056. On August 6, 2024, the Company issued 100,000 shares of common stock to Robert Stutman, a member of the Company s Board of Directors, as compensation, valued at 253. On August 6, 2024, the Company issued 50,000 shares of common stock to Jesse Anglen, a member of the Company s Board of Directors, as compensation, valued at 126. On August 6, 2024, the Company issued 50,000 shares of common stock to Adrian Neilan, a member of the Company s Board of Directors, as compensation, valued at 126. On August 6, 2024, the Company issued 50,000 shares of common stock to Jesse Vern Barkdull, a member of the Company s Board of Directors, as compensation, valued at 126. On August 6, 2024, the Company issued 30,000 shares of common stock to Alan Klitenic in consideration of his appointment as a member of the Company s Board of Advisors, valued at 76. On August 26, 2024, the Company issued 1,333,333 shares of common stock to Dataark for the acquisition of 8 of the database software and related technology assets described above, valued at 3,371. The above-described shares were issued pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder, as there was no general solicitation, the shareholders were accredited and/or financially sophisticated, and the transactions did not involve a public offering. ITEM 4. MINE SAFETY DISCLOSURES. None. ITEM 5. OTHER INFORMATION. None. 9 Table of Contents ITEM 6. EXHIBITS. Exhibit Description 3.1 Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 3.2 Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014) 10.1 Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015) 10.2 Board Member Agreement, by and between the Company and Robert Stutman, dated March 26, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 1, 2024) 10.3 Board Member Agreement, by and between the Company and Adrian Neilan, dated March 26, 2024 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 1, 2024) 10.4 Board Member Agreement, by and between the Company and Jesse Anglen, dated March 26, 2024 (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on April 1, 2024) 10.5 Board Member Agreement, by and between the Company and Vern Barkdull, dated March 26, 2024 (incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on April 1, 2024) 10.6 Revenue Sharing Agreement, by and between the Company and Dark Bull, dated July 13, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on July 18, 2024) 10.7 Software Purchase and Development Agreement between AMJ Global Technology and Dataark Systems LLC, dated August 25, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 27, 2024) 31.1/31.2 Certification of Chief Executive Officer and Chief Executive Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1/32.2 Certification of Chief Executive Officer and Chief Executive Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63 101 Inline XBRL Document Set for the condensed financial statements and accompanying notes in Part I, Item 1, Financial Statements of this Quarterly Report on Form 10-Q. 104 Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. ____________ Filed herewith. 10 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. AMJ Global Technology Date: October 23, 2024 By: /s/ Dr. Arthur Malone, Jr. Dr. Arthur Malone, Jr. Chief Executive Officer, Chief Financial Officer and Director 11 

<EX-31.1>
 2
 kgnr_ex311.htm
 CERTIFICATION
 
 kgnr_ex311.htm EXHIBIT 31.1/31.2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING AND FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT AND RULE 13A-14(A) OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934 I, Dr. Arthur Malone Jr., certify that: 1. I have reviewed this report on Form 10-Q of AMJ Global Technology, for the quarter ended August 31, 2024; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant s internal control over financial reporting that occurred during the registrant s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant s internal control over financial reporting; and 5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant s auditors and the audit committee of registrant s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant s internal control over financial reporting. Date: October 23, 2024 By: /s/ Dr. Arthur Malone, Jr. Dr. Arthur Malone, Jr. Chief Executive Officer, Chief Financial Officer and Director 

</EX-31.1>

<EX-32.1>
 3
 kgnr_ex321.htm
 CERTIFICATION
 
 kgnr_ex321.htm EXHIBIT 32.1/32.2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING AND FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of AMJ Global Technology (the Company ), for the quarter ended August 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report ), I, Dr. Arthur Malone, Jr., Chief Executive Officer, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. Date: October 23, 2024 By: /s/ Dr. Arthur Malone, Jr. Dr. Arthur Malone, Jr. Chief Executive Officer, Chief Financial Officer and Director 

</EX-32.1>

<EX-101.SCH>
 4
 kgnr-20240831.xsd
 XBRL TAXONOMY EXTENSION SCHEMA

</EX-101.LAB>

<EX-101.CAL>
 6
 kgnr-20240831_cal.xml
 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

</EX-101.CAL>

<EX-101.PRE>
 7
 kgnr-20240831_pre.xml
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

</EX-101.PRE>

<EX-101.DEF>
 8
 kgnr-20240831_def.xml
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

</EX-101.DEF>

